‹ All stocks
Faeth Therapeutics
FTH · NASDAQ · Healthcare
$27.86
▼ $27.86 (-1.63%)
Day range
$27.37 – $28.79
Year range
$7.45 – $42.14
Open
$28.32
Previous close
—
Market cap
$718.18M
Volume (24h)
$40.2K
Volume (52w)
$1.12M
Performance
7D
▲ 0.32%
1M
▼ -28.78%
3M
▲ 13.76%
6M
▼ -16.54%
1Y
▲ 196.38%
YTD
▲ 188.70%
3Y
▲ 96.19%
5Y
▼ -85.81%
All-time
▼ -92.63%
Key statistics
P/E ratio
-0.20
EPS (TTM)
$-141.65
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
25.8M
About Faeth Therapeutics
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |